Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN N : 3M, Qiagen to comply with Biden's COVID-19 vaccination, test mandate

09/10/2021 | 07:04pm EDT

Sept. 10 (Reuters) - 3M Co, the biggest U.S. producer of N95 masks, and German genetic testing specialist Qiagen said separately on Friday that they will comply with the Biden administration's new COVID-19 vaccination and testing mandate for workplaces.

"We strongly support all initiatives aiming to increase vaccination rates especially at the workplace," Qiagen told Reuters in an email.

Qiagen said it had already updated its policies to make vaccination compulsory for certain employee groups at its U.S. locations.

3M, the diversified manufacturer which makes everything from Post-It notes and adhesives to industrial sandpaper, said it will comply with the mandate while also adding that it was strongly encouraging its employees to get vaccinated.

U.S. President Joe Biden on Thursday announced policies requiring most federal employees to get COVID-19 vaccinations and pushing large and small private employers to have their workers inoculated or tested weekly.

The White House said it will spend nearly $2 billion on 280 million rapid COVID-19 tests to support the drive.

Abbott Laboratories, one of the largest U.S. manufacturers of rapid COVID-19 tests, said it was quickly working to scale up manufacturing of its two tests - BinaxNOW and ID NOW test kits - including hiring additional employees.

Increased capacity will ensure availability of tens of millions more tests in the coming weeks and months, the medical device maker said.

The new vaccination mandate could apply to as many as 100 million Americans - close to two-thirds of the country's workforce - and amount to Biden's strongest push yet for inoculation.

Southwest Airlines Co, which has more than 54,000 employees, said it was prepared to move toward compliance with the mandate.

"We continue to strongly encourage our Employees to seek and obtain vaccination, and to share their vaccination status with us," the company said. (Reporting by Mrinalika Roy, Sanjana Shivdas in Bengaluru; Additional reporting by Shubham Kalia; Editing by Shinjini Ganguli and Shailesh Kuber)


© Reuters 2021
All news about QIAGEN N.V.
09:21aQIAGEN N.V. : to Release Results for Q3 2021 and First Nine Months of 2021
BU
10/19QIAGEN N : Launches QIAreach Quanti-FERON-TB for TB Testing in High Burden Regions
MT
10/19QIAGEN N : Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Region..
BU
10/19QIAGEN N.V. Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Re..
CI
10/19QIAGEN N.V. : Release of a capital market information
EQ
10/19QIAGEN N.V. : Release of a capital market information
DJ
10/14QIAGEN N : Redburn Starts Qiagen NV at Buy
MT
10/12QIAGEN N.V. : Release of a capital market information
DJ
10/08QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
DJ
10/08QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German Securitie..
EQ
More news
Analyst Recommendations on QIAGEN N.V.
More recommendations
Financials (USD)
Sales 2021 2 157 M - -
Net income 2021 449 M - -
Net Debt 2021 942 M - -
P/E ratio 2021 26,7x
Yield 2021 -
Capitalization 11 923 M 11 923 M -
EV / Sales 2021 5,97x
EV / Sales 2022 6,12x
Nbr of Employees 5 900
Free-Float 98,3%
Chart QIAGEN N.V.
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 52,57 $
Average target price 55,96 $
Spread / Average Target 6,45%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.-0.53%11 923
MODERNA, INC.219.34%134 660
LONZA GROUP AG27.07%58 240
IQVIA HOLDINGS INC.38.99%47 715
SEAGEN INC.-0.54%31 691
CELLTRION, INC.-39.28%25 332